Cancer treatment maker BioCold Genesys lands $22M in funds By: L.A. Biz via Business Journals March 18, 2019 at 17:22 PM EDT Cold Genesys, Inc., a biopharmaceutical company developing novel immunotherapies used to treat cancer, has closed on $22 million in financing. Read More >>